Amiloride is a cholinergic antagonist in the rabbit pancreas.
The effect of amiloride on fluid and protein secretion in the isolated rabbit pancreas and on amylase secretion in rabbit pancreatic acini has been studied. Amiloride (1 mM) has no effect on the pancreatic fluid secretion either in a normal incubation medium (143 mM Na+), or in a medium containing only 25 mM Na+. The carbachol-induced enzyme secretion is inhibited by amiloride in both systems, whereas the enzyme secretion induced by the C-terminal octapeptide of cholecystokinin ( PzO ) is not affected. Amiloride also inhibits the carbachol-induced 45Ca efflux from rabbit pancreatic acini, but again not that induced by PzO . The amiloride concentrations for half-maximal inhibition of carbachol-induced amylase secretion and 45Ca efflux are 40 and 80 microM, respectively. Amiloride also competitively inhibits the specific binding of [3H]quinuclidinyl benzylate ( [3H]QNB) to rabbit pancreatic acini, suggesting that the amiloride effect is due to competition on the level of the muscarinic acetylcholine receptor.
D000109:Acetylcholine / Q000037:antagonists & inhibitors*; D000584:Amiloride / Q000494:pharmacology*; D000681:Amylases / Q000378:metabolism*; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002217:Carbachol / Q000494:pharmacology*; D066298:In Vitro Techniques; D007700:Kinetics; D010179:Pancreas / Q000502:physiology*; D010189:Pancreatic Juice / Q000187:drug effects / Q000378:metabolism*; D011719:Pyrazines / Q000494:pharmacology*; D011813:Quinuclidinyl Benzilate / Q000378:metabolism; D011817:Rabbits; D011976:Receptors, Muscarinic / Q000187:drug effects / Q000378:metabolism*
D011719:Pyrazines; D011976:Receptors, Muscarinic; D011813:Quinuclidinyl Benzilate; D000584:Amiloride; D002217:Carbachol; D000681:Amylases; D000109:Acetylcholine; D002118:Calcium